End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4272 USD | -3.87% | +6.37% | -12.30% |
04-30 | Akili, Inc. Plans to Continue to Pursue Marketing Authorization from the U.S. Food and Drug Administration for Its EndeavorOTC Product | CI |
04-30 | Akili, Inc. to Reduce Workforce | CI |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
EBIT
Cash or Net Debt
- Stock Market
- Equities
- AKLI Stock
- Revisions Akili, Inc.